The present study, together with evidence from AHDS patients16, argues that the pathophysiological consequences of MT3-impaired signaling are not only related to decreased neural cell diversity13,27,30, but also to the consequences on CNS vascularization. This evidence concerns the gene MT3 and Allan-Herndon-Dudley syndrome.